Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 66 member 2 (SLC66A2) is a predicted membrane transporter protein belonging to the solute carrier (SLC) superfamily, specifically classified within the SLC66 family[9]. The protein is thought to participate in phospholipid translocation and retrograde transport, moving molecules from the endosome to the Golgi network[1][4]. SLC66A2 is localized to membrane compartments, including the cytosol, endosome, and trans-Golgi network[1][4]. While biochemical evidence supports transporter activity for some SLC66 family members, SLC66A2's precise substrate specificity and physiological function remain incompletely characterized[9]. The gene is protein-coding and is associated with certain rare diseases and various normal tissue expressions, but it is not a well-established therapeutic target with approved drugs or demonstrated disease-modifying drugs to date[4][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 66 member 2 (SLC66A2).